Skip to content
Skip over generic navigation
Skip over primary navigation
Skip over visual
Skip over functional column
In times of increasing product rationalization, expanding quality requirements and easy powder handling for food and pharma applications our customer can now benefit from the enhanced quality of AEROSIL® 200 Pharma. Different quality standards are now combined in one product providing HACCP and IPEC-GMP! Capitalize the advantage of AEROSIL® 200 Pharma for your food and pharma production.
AEROSIL® fumed silica increase the hardness and abrasivity resistance of dental composites. In addition, they reduce the edge gap that can occur when the composite is cured.
AEROSIL® fumed silica are excellently suited as fillers for dental impression materials. They improve properties such as tensile strength, elongation at break and tear resistance.
This Industry Brochure presents our special "Pharma-Grades" as part of the AEROSIL® product portfolio. The Pharma grades differ from our other products in that they are manufactured and handled according to good manufacturing practices (GMP) guidelines for pharmaceutical excipients as established by the International Pharmaceutical Excipients Council (IPEC). In addition each lot is fully tested according to Ph. Eur., USP/NF, (if applicable, JP) and supplied with an appropiate certificate of analysis. In addition to regulatory information, the brochure addresses the various pharmaceutical applications of AEROSIL® 200 Pharma, AEROSIL® R 972 Pharma, AEROPERL® 300 Pharma and our newest product AEROSIL® 300 Pharma. These include solid (e.g. tablets), semi-solid (e.g. suppositories) and liquid (e.g. gels, creams) dosage forms. Tables are used to summarize the effects that can be achieved and the recommended products.
The Technical Information No. 1281 is a brochure describing the use of AEROSIL® colloidal silicon dioxide products in various pharmaceutical dosage forms. The brochure also includes information on our newest product, AEROSIL® R 972 Pharma, as well as on AEROPERL® 300 Pharma granulated colloidal silicon dioxide. Extensive references to the scientific literature on each topic help formulators gain even more detailed information on many topics.
With this brochure we would like to introduce a group of products which has recently been developed to provide high purity fumed silica and fumed metal oxides with improved properties in various applications to our customers: the AEROPERL® product line.
AEROSIL® colloidal silicon dioxide has been used as apharmaceutical excipient since the early days of directcompression tableting. AEROSIL® 200 Pharma is the traditionalglidant, helping to obtain the optimal powder fl owrequired by today’s high speed tablet presses. Since the timethat AEROSIL® 200 Pharma was fi rst used as a glidant, challengesin formulating solid dosage forms have become morecomplex. Tablet powders of diff erent average particle size,composition and moisture sensitivity are common in the industry– requiring specialized products to be able to compete in anincreasingly cost sensitive health care environment.
The first edition of our "Pharma Silica Insights" newsletter introduces AEROPERL® 300 Pharma as the latest addition to our AEROSIL® Pharma portfolio and how this product can be used to increase the solubility of poorly soluble active pharmaceutical ingredients.
Topic:- AEROSIL® and AEROPERL® colloidal silicon dioxide pave the way to ICH Q3D compliant formulations